MICROALBUMINURIA AND LOW HEMOGLOBIN AS RISK FACTORS FOR THE OCCURRENCE AND INCREASING SEVERITY OF DIABETIC RETINOPATHY.

Dr. Varada. S. N. Kameswari

Abstract


Aim: To assess the influence of urinary microalbuminuria and hemoglobin concentration on the occurrence and severity of diabetic retinopathy (DR).
Materials and Methods: In this prospective cross-sectional study carried out over a period of 1 year, type 2 diabetic patients seeking ocular evaluation for DR were assessed for presence and severity of DR.
Results: out of 100 patients were included in the study. DR of any grade was seen in 43 patients, Duration of diabetes (P < 0.001), microalbuminuria (P < 0.001) and low hemoglobin (P = 0.001)were found to be highly significant risk factors for the development and increasing severity of DR.
Conclusion: Microalbuminuria and low hemoglobin are strong predictors for DR, in type 2 diabetics., Although not directly involved in the pathogenesis, microalbuminuria can help in identifying patients at risk for more severe diabetic eye disease.
Microalbuminuria warrants intensive monitoring of both retinal and renal status. The hemoglobin levels should be monitored regularly in diabetic patients to detect and treat anaemia so that we reduce one risk factor for DR.


Keywords


microalbuminuria, hemoglobin, Diabetic retinopathy (DR)

Full Text:

PDF

References


Klein R, Klein B. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992;15:1875-91. 2.Yanko L, Goldbourt U, Michelson IC, Shapiro A, Yaari S. Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men. Br J Ophthalmol 1983;67:759-65. 3.Klein R, Klein BE, Moss SE, Cruickshank KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-28. 4.Diabetic Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetic Control and Complications Trial. Ophthalmology 1995;102:647-61 5.Chew EY, Mills JL, Metzger BE, Remaley NA, Jovanic-Peterson L, Knopp RH, et al. Metabolic control and progression of diabetic retinopathy. The Diabetes in Early Pregnancy Study. Diabetes Care 1995;18:631-7.


Refbacks

  • There are currently no refbacks.